Complejo Asistencial Universitario de Salamanca - Hospital Clínico

Salamanca 37007

2 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Myelomonocytic Leukemia, Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelodysplastic Syndrome/Neoplasm, Myelodysplastic Syndromes, Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Refractory B-Cell Non-Hodgkin Lymphoma

Studies at this site

• A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) — Recruiting now
• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) — Running, not enrolling
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed
• A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) — Completed